The Effectiveness Of Sorafenib In Newly Diagnosed HCC

Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses The Effectiveness Of Sorafenib In Newly Diagnosed HCC. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com